NGL Fine-Chem Limited Share Price & Analysis
₹2,742.6▲ +6.23%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹2,742.6
+6.23%
Open
₹—
High
₹2,850
Low
₹2,589.8
Close
₹2,742.6
52W High
₹3,005
52W Low
₹980
Volume
40K
Lot Size
1
Sector
Healthcare
Market Cap
₹2K Cr
Face Value
₹5
Small Cap
Price Chart
Fundamentals
P/E
34.2
Sector P/E
48.9
P/B
4.98
EPS
₹77.82
ROE
15.7%
ROCE
17%
D/E Ratio
0.33
Div Yield
0.07%
Book Value
₹533
+
Strengths
- ✓Strong return on equity (ROE 15.7%)
- ✓Efficient capital deployment (ROCE 17%)
- ✓Attractively valued vs sector (P/E 34.2x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
NGLFINE · as of Mar 2026
Promoters72.74%
Public27.26%▲0.03
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.06% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| FII | 0.04% | 0.10% | 0.03% | 0.02% | 0.05% | — |
| Public | 26.91% | 27.16% | 27.24% | 27.25% | 27.23% | 27.26% |
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹128 Cr ▲6.7% | ₹120 Cr ▲15.4% | ₹104 Cr ▲9.5% | ₹95 Cr ▲6.7% | ₹89 Cr ▼4.3% | ₹93 Cr ▲2.2% | ₹91 Cr ▼9.0% | ₹100 Cr |
| Op. Profit | ₹22 Cr ▲29.4% | ₹17 Cr ▲54.5% | ₹11 Cr ▲83.3% | ₹6 Cr ▲20.0% | ₹5 Cr ▼58.3% | ₹12 Cr ▲33.3% | ₹9 Cr ▼43.8% | ₹16 Cr |
| OPM | 18.0% ▲28.6% | 14.0% ▲27.3% | 11.0% ▲57.1% | 7.0% ▲16.7% | 6.0% ▼50.0% | 12.0% ▲20.0% | 10.0% ▼37.5% | 16.0% |
| Net Profit | ₹16 Cr ▲60.0% | ₹10 Cr ▲11.1% | ₹9 Cr ▲800.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼90.0% | ₹10 Cr ▲11.1% | ₹9 Cr ▼25.0% | ₹12 Cr |
| EPS (₹) | 25.4 ▲62.9% | 15.59 ▲4.2% | 14.96 ▲1619.5% | 0.87 ▼58.0% | 2.07 ▼87.0% | 15.88 ▲6.4% | 14.92 ▼25.2% | 19.94 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹368 Cr ▲8.6% | ₹339 Cr ▲21.9% | ₹278 Cr ▼12.6% | ₹318 Cr ▲23.3% | ₹258 Cr ▲69.7% | ₹152 Cr ▼0.7% | ₹153 Cr |
| Expenses | ₹333 Cr ▲16.8% | ₹285 Cr ▲17.3% | ₹243 Cr ▼2.4% | ₹249 Cr ▲39.9% | ₹178 Cr ▲36.9% | ₹130 Cr ▲7.4% | ₹121 Cr |
| Op. Profit | ₹35 Cr ▼35.2% | ₹54 Cr ▲54.3% | ₹35 Cr ▼48.5% | ₹68 Cr ▼15.0% | ₹80 Cr ▲263.6% | ₹22 Cr ▼31.3% | ₹32 Cr |
| OPM | 9.0% ▼43.8% | 16.0% ▲23.1% | 13.0% ▼38.1% | 21.0% ▼32.3% | 31.0% ▲121.4% | 14.0% ▼33.3% | 21.0% |
| Other Income | ₹9 Cr ▼35.7% | ₹14 Cr ▲133.3% | ₹6 Cr ▼45.5% | ₹11 Cr ▲37.5% | ₹8 Cr ▲700.0% | ₹1 Cr ▼75.0% | ₹4 Cr |
| Interest | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▲0.0% | ₹3 Cr |
| Depreciation | ₹12 Cr ▲0.0% | ₹12 Cr ▲9.1% | ₹11 Cr ▲10.0% | ₹10 Cr ▲25.0% | ₹8 Cr ▲0.0% | ₹8 Cr ▲33.3% | ₹6 Cr |
| PBT | ₹28 Cr ▼48.1% | ₹54 Cr ▲100.0% | ₹27 Cr ▼59.7% | ₹67 Cr ▼14.1% | ₹78 Cr ▲550.0% | ₹12 Cr ▼57.1% | ₹28 Cr |
| Tax % | 24.0% ▲0.0% | 24.0% ▼4.0% | 25.0% ▲0.0% | 25.0% ▼7.4% | 27.0% ▼12.9% | 31.0% ▲14.8% | 27.0% |
| Net Profit | ₹21 Cr ▼48.8% | ₹41 Cr ▲105.0% | ₹20 Cr ▼60.0% | ₹50 Cr ▼12.3% | ₹57 Cr ▲612.5% | ₹8 Cr ▼60.0% | ₹20 Cr |
| EPS (₹) | 34.19 ▼48.9% | 66.88 ▲101.6% | 33.18 ▼58.9% | 80.77 ▼12.0% | 91.81 ▲580.1% | 13.5 ▼58.6% | 32.58 |
| Div Payout | 5.0% ▲66.7% | 3.0% ▼40.0% | 5.0% ▲150.0% | 2.0% ▲0.0% | 2.0% ▼84.6% | 13.0% ▲160.0% | 5.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||
| Equity Capital | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr |
| Reserves | ₹297 Cr ▲6.5% | ₹279 Cr ▲7.3% | ₹260 Cr ▲18.7% | ₹219 Cr ▲9.5% | ₹200 Cr ▲32.5% | ₹151 Cr ▲57.3% | ₹96 Cr ▲7.9% | ₹89 Cr |
| Borrowings | ₹88 Cr ▲14.3% | ₹77 Cr ▲126.5% | ₹34 Cr ▲6.3% | ₹32 Cr ▲6.7% | ₹30 Cr ▲87.5% | ₹16 Cr ▼42.9% | ₹28 Cr ▲3.7% | ₹27 Cr |
| Other Liabilities | ₹96 Cr ▲29.7% | ₹74 Cr ▲25.4% | ₹59 Cr ▲84.4% | ₹32 Cr ▼27.3% | ₹44 Cr ▲22.2% | ₹36 Cr ▲38.5% | ₹26 Cr ▲13.0% | ₹23 Cr |
| Total Liabilities | ₹484 Cr ▲11.8% | ₹433 Cr ▲21.6% | ₹356 Cr ▲24.0% | ₹287 Cr ▲3.6% | ₹277 Cr ▲33.8% | ₹207 Cr ▲34.4% | ₹154 Cr ▲8.5% | ₹142 Cr |
| Assets | ||||||||
| Fixed Assets | ₹170 Cr ▲18.9% | ₹143 Cr ▲66.3% | ₹86 Cr ▼2.3% | ₹88 Cr ▼1.1% | ₹89 Cr ▲39.1% | ₹64 Cr ▼5.9% | ₹68 Cr ▲11.5% | ₹61 Cr |
| CWIP | ₹35 Cr ▼30.0% | ₹50 Cr ▲8.7% | ₹46 Cr ▲76.9% | ₹26 Cr ▲333.3% | ₹6 Cr ▼50.0% | ₹12 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹49 Cr ▼18.3% | ₹60 Cr ▲11.1% | ₹54 Cr ▲38.5% | ₹39 Cr ▲34.5% | ₹29 Cr ▲0.0% | ₹29 Cr ▲163.6% | ₹11 Cr ▲22.2% | ₹9 Cr |
| Other Assets | ₹230 Cr ▲27.1% | ₹181 Cr ▲5.8% | ₹171 Cr ▲28.6% | ₹133 Cr ▼13.1% | ₹153 Cr ▲50.0% | ₹102 Cr ▲36.0% | ₹75 Cr ▲2.7% | ₹73 Cr |
| Total Assets | ₹484 Cr ▲11.8% | ₹433 Cr ▲21.6% | ₹356 Cr ▲24.0% | ₹287 Cr ▲3.6% | ₹277 Cr ▲33.8% | ₹207 Cr ▲34.4% | ₹154 Cr ▲8.5% | ₹142 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹36 Cr ▲80.0% | ₹20 Cr ▼42.9% | ₹35 Cr ▲150.0% | ₹14 Cr ▼48.1% | ₹27 Cr ▲35.0% | ₹20 Cr ▲122.2% | ₹9 Cr |
| Investing CF | ₹-35 Cr ▼29.6% | ₹-27 Cr ▲0.0% | ₹-27 Cr ▼92.9% | ₹-14 Cr ▲44.0% | ₹-25 Cr ▼25.0% | ₹-20 Cr ▼100.0% | ₹-10 Cr |
| Financing CF | ₹-1 Cr ▲0.0% | ₹-1 Cr ▲0.0% | ₹-1 Cr ▲0.0% | ₹-1 Cr ▲0.0% | ₹-1 Cr ▲0.0% | ₹-1 Cr | ₹0 Cr |
| Net Cash Flow | ₹0 Cr ▲100.0% | ₹-7 Cr ▼200.0% | ₹7 Cr ▲800.0% | ₹-1 Cr ▼150.0% | ₹2 Cr | ₹0 Cr ▲100.0% | ₹-1 Cr |
| Free Cash Flow | ₹-38 Cr ▼375.0% | ₹-8 Cr ▼260.0% | ₹5 Cr ▲133.3% | ₹-15 Cr ▼250.0% | ₹10 Cr ▲66.7% | ₹6 Cr ▲200.0% | ₹-6 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 81d ▼16.5% | 97d ▲12.8% | 86d ▲16.2% | 74d ▲39.6% | 53d ▼15.9% | 63d ▼20.3% | 79d |
| Inventory Days | 101d ▲3.1% | 98d ▲42.0% | 69d ▼49.6% | 137d ▲3.8% | 132d ▼14.8% | 155d ▲46.2% | 106d |
| Days Payable | 113d ▲0.9% | 112d ▲77.8% | 63d ▼30.8% | 91d ▼11.7% | 103d ▼11.2% | 116d ▲26.1% | 92d |
| Cash Conv. Cycle | 68d ▼18.1% | 83d ▼10.8% | 93d ▼22.5% | 120d ▲46.3% | 82d ▼19.6% | 102d ▲9.7% | 93d |
| Working Capital Days | 50d ▼34.2% | 76d ▲11.8% | 68d ▼24.4% | 90d ▲30.4% | 69d ▲19.0% | 58d ▼17.1% | 70d |
| ROCE | 9.0% ▼55.0% | 20.0% ▲66.7% | 12.0% ▼64.7% | 34.0% ▼37.0% | 54.0% ▲285.7% | 14.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is NGL Fine-Chem Limited share price today?▾
NGL Fine-Chem Limited (NGLFINE) is currently trading at ₹2,742.6 on NSE, up 6.23% as of the last market session. Prices update daily after market close on MarketNetra.
Is NGL Fine-Chem Limited available in F&O (Futures & Options)?▾
Yes, NGL Fine-Chem Limited (NGLFINE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is NGL Fine-Chem Limited 52-week high and low?▾
NGL Fine-Chem Limited's 52-week high is ₹3,005 and the 52-week low is ₹980. The current price of ₹2,742.6 is 8.7% below the 52W high.
What is NGL Fine-Chem Limited P/E ratio?▾
NGL Fine-Chem Limited's current P/E ratio is 34.2. This indicates the market is paying ₹34.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade NGL Fine-Chem Limited options?▾
NGL Fine-Chem Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade NGLFINE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.